0001576280-24-000092.txt : 20240416 0001576280-24-000092.hdr.sgml : 20240416 20240416183519 ACCESSION NUMBER: 0001576280-24-000092 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240415 FILED AS OF DATE: 20240416 DATE AS OF CHANGE: 20240416 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Saia John G. CENTRAL INDEX KEY: 0001737840 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 24848996 MAIL ADDRESS: STREET 1: C/O ACELRX PHARMACEUTICALS, INC. STREET 2: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER NAME: FORMER CONFORMED NAME: Saia John DATE OF NAME CHANGE: 20180417 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 4 1 wk-form4_1713306910.xml FORM 4 X0508 4 2024-04-15 0 0001576280 Guardant Health, Inc. GH 0001737840 Saia John G. 3100 HANOVER STREET PALO ALTO CA 94304 0 1 0 0 Chief Legal Officer 0 Common Stock 2024-04-15 4 F 0 1108 17.06 D 20797 D Common Stock 2024-04-15 4 M 0 7569 0 A 28366 D Common Stock 2024-04-15 4 F 0 2701 17.06 D 25665 D Restricted Stock Units 0 2024-04-15 4 M 0 7569 0 D Common Stock 7569 15137 D These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. The restricted stock units granted on August 8, 2022 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of April 15, 2022, and the remaining 75% annually during the three-year period thereafter. Not applicable for Restricted Stock Units. /s/ John G. Saia 2024-04-16